Semler Scientific Inc. and Bard Peripheral Vascular Inc.

FL 2025 Clinical Laboratories
DOJ False Claims Act
Penalty
$29.8 million

Outcome

Semler Scientific Inc. and Bard Peripheral Vascular Inc. to Pay Nearly $37M to Resolve False Claims Act Allegations Relating to FloChec and QuantaFlo Devices

Details

Semler Scientific Inc. and Bard Peripheral Vascular Inc. — DOJ Enforcement (2025)

Outcome: Semler Scientific Inc. and Bard Peripheral Vascular Inc. to Pay Nearly $37M to Resolve False Claims Act Allegations Relating to FloChec and QuantaFlo Devices

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.

Source: DOJ Press Release — Semler Scientific Inc. and Bard Peripheral Vascular Inc. to Pay Nearly $37M to Resolve False Claims Act Allegations Relating to FloChec and QuantaFlo

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works